Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz or Nelfinavir + IDV/3TC/ZDV in Advanced HIV
NCT00000903Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial of efavirenz and nelfinavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Time to a virologic failure. Status: completed.
02
Drugs
efavirenznelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000903.